Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 5
2006 6
2007 1
2008 4
2009 2
2010 3
2011 4
2012 5
2013 4
2014 3
2015 4
2016 3
2017 4
2018 4
2019 1
2020 7
2021 10
2022 6
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.
Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Marsh D, Clancy M, Bradley L, Wisniewski L, Carper BA, Thomas SM, McCrae KR. Al-Samkari H, et al. Among authors: parambil j. N Engl J Med. 2024 Sep 19;391(11):1015-1027. doi: 10.1056/NEJMoa2312749. N Engl J Med. 2024. PMID: 39292928 Free PMC article. Clinical Trial.
Hereditary Hemorrhagic Telangiectasia.
Parambil JG. Parambil JG. Clin Chest Med. 2016 Sep;37(3):513-21. doi: 10.1016/j.ccm.2016.04.013. Epub 2016 Jun 10. Clin Chest Med. 2016. PMID: 27514597 Review.
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Galiè N, et al. N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687. N Engl J Med. 2015. PMID: 26308684 Free article. Clinical Trial.
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
Long-Term Oxygen Treatment Trial Research Group; Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos RJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Stoller JK, Wise R, Yusen RD, Tonascia J, Sternberg AL, Bailey W. Long-Term Oxygen Treatment Trial Research Group, et al. N Engl J Med. 2016 Oct 27;375(17):1617-1627. doi: 10.1056/NEJMoa1604344. N Engl J Med. 2016. PMID: 27783918 Free PMC article. Clinical Trial.
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.
Al-Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, Vázquez C, Serra MM, Dupuis-Girod S, Wilsen CB, McWilliams JP, Fountain EH, Gossage JR, Weiss CR, Latif MA, Issachar A, Mei-Zahav M, Meek ME, Conrad M, Rodriguez-Lopez J, Kuter DJ, Iyer VN. Al-Samkari H, et al. Among authors: parambil jg. Haematologica. 2021 Aug 1;106(8):2161-2169. doi: 10.3324/haematol.2020.261859. Haematologica. 2021. PMID: 32675221 Free PMC article.
Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results.
Nathan SD, Argula R, Trivieri MG, Aziz S, Gay E, Medarov B, Parambil J, Raina A, Risbano MG, Thenappan T, Soto JS, Bell H, Lacasse V, Sista P, Di Marino M, Smart A, Hawkes B, Nelson E, Bull T, Tapson V, Waxman A. Nathan SD, et al. Among authors: parambil j. Eur Respir J. 2024 Jun 6;63(6):2400172. doi: 10.1183/13993003.00172-2024. Print 2024 Jun. Eur Respir J. 2024. PMID: 38811045 Free PMC article. Clinical Trial.
Pulmonary hypertension caused by sarcoidosis.
Diaz-Guzman E, Farver C, Parambil J, Culver DA. Diaz-Guzman E, et al. Among authors: parambil j. Clin Chest Med. 2008 Sep;29(3):549-63, x. doi: 10.1016/j.ccm.2008.03.010. Clin Chest Med. 2008. PMID: 18539244 Free PMC article. Review.
Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis.
Trainee Collaborative for Research and Audit in Hepatology UK. Electronic address: [email protected]; Trainee Collaborative for Research and Audit in Hepatology UK. Trainee Collaborative for Research and Audit in Hepatology UK. Electronic address: [email protected], et al. J Hepatol. 2023 Oct;79(4):e165-e167. doi: 10.1016/j.jhep.2023.05.035. Epub 2023 Jun 12. J Hepatol. 2023. PMID: 37315808 No abstract available.
Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management.
Kattih Z, Bade B, Hatabu H, Brown K, Parambil J, Hata A, Mazzone PJ, Machnicki S, Guerrero D, Chaudhry MQ, Kellermeyer L, Johnson K, Cohen S, Ramdeo R, Naidich J, Borczuck A, Raoof S. Kattih Z, et al. Among authors: parambil j. Chest. 2024 Oct 10:S0012-3692(24)05294-2. doi: 10.1016/j.chest.2024.09.033. Online ahead of print. Chest. 2024. PMID: 39393485 Review.
75 results